Guardant Health (GH) Net Cash Flow (2017 - 2026)

Guardant Health (GH) has 10 years of Net Cash Flow data on file, last reported at $612.2 million in Q1 2026.

• Quarterly Net Cash Flow rose 253.22% year-over-year to $612.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $298.1 million (up 191.56% YoY) and the FY2025 annual result came in at -$140.8 million, up 71.96% from the prior year.
• Net Cash Flow climbed to $612.2 million in Q1 2026 per GH's latest filing, from -$199.4 million in the prior quarter.
• The five-year high for Net Cash Flow was $675.3 million in Q4 2023, with the low at -$356.9 million in Q2 2022.
• Average Net Cash Flow over 5 years is $36.1 million, with a median of -$17.8 million recorded in 2022.
• Year-over-year, Net Cash Flow slumped 614.42% in 2022 and jumped 5365.04% in 2025.
• Guardant Health's Net Cash Flow stood at -$17.8 million in 2022, then surged by 3892.93% to $675.3 million in 2023, then sank by 108.43% to -$56.9 million in 2024, then sank by 250.35% to -$199.4 million in 2025, then surged by 407.01% to $612.2 million in 2026.
• Business Quant data shows GH's Net Cash Flow at $612.2 million in Q1 2026, -$199.4 million in Q4 2025, and -$45.4 million in Q3 2025.